{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:46:18Z","timestamp":1792809978276,"version":"4.5.0"},"reference-count":65,"publisher":"LLC Obyedinennaya Redaktsiya","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2016]]},"DOI":"10.17116\/terarkh20168854-12","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T11:47:58Z","timestamp":1464176878000},"page":"4","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular disease in rheumatic diseases"],"prefix":"10.26442","volume":"88","author":[{"given":"E. L.","family":"Nasonov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. V.","family":"Popkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. S.","family":"Novikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh20168854-12-1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut"},{"key":"key-10.17116\/terarkh20168854-12-2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030297"},{"key":"key-10.17116\/terarkh20168854-12-3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12395"},{"key":"key-10.17116\/terarkh20168854-12-4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.07.018"},{"key":"key-10.17116\/terarkh20168854-12-5","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22554"},{"key":"key-10.17116\/terarkh20168854-12-6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.08.004"},{"key":"key-10.17116\/terarkh20168854-12-7","doi-asserted-by":"crossref","unstructured":"Nasonov E, Gordeev A, Galushko E. Rheumatic diseases and multimorbidity. Terapevticheskii arkhiv. 2015;5:4-9. (In Russ.)","DOI":"10.17116\/terarkh20158754-9"},{"key":"key-10.17116\/terarkh20168854-12-8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.07.010"},{"key":"key-10.17116\/terarkh20168854-12-9","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.112"},{"key":"key-10.17116\/terarkh20168854-12-10","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.206"},{"key":"key-10.17116\/terarkh20168854-12-11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.123919"},{"key":"key-10.17116\/terarkh20168854-12-12","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2014-477-494"},{"key":"key-10.17116\/terarkh20168854-12-13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204573"},{"key":"key-10.17116\/terarkh20168854-12-14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"key-10.17116\/terarkh20168854-12-15","doi-asserted-by":"crossref","unstructured":"Ross R. Atherosclerosis \u2014 an inflammatory disease. N Engl J Med. 1999;340:115.","DOI":"10.1056\/NEJM199901143400207"},{"key":"key-10.17116\/terarkh20168854-12-16","doi-asserted-by":"crossref","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.","DOI":"10.1056\/NEJMra043430"},{"key":"key-10.17116\/terarkh20168854-12-17","doi-asserted-by":"publisher","DOI":"10.1038\/nature10146"},{"key":"key-10.17116\/terarkh20168854-12-18","doi-asserted-by":"crossref","unstructured":"Pasceri V, Yeh ET. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation. 1999;100:2124-2126.","DOI":"10.1161\/01.CIR.100.21.2124"},{"key":"key-10.17116\/terarkh20168854-12-19","unstructured":"Nasonov E. Atherothrombosis problem in rheumatology. Vestnik RAMN. 2003;7:6-10. (In Russ.)"},{"key":"key-10.17116\/terarkh20168854-12-20","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.40"},{"key":"key-10.17116\/terarkh20168854-12-21","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304475"},{"key":"key-10.17116\/terarkh20168854-12-22","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2013-1506"},{"key":"key-10.17116\/terarkh20168854-12-23","unstructured":"Popkova T, Novikova D, Nasonov E. Atherosclerosis in rheumatic diseases. In the book: Genetically engineered biological agents in the treatment of rheumatoid arthritis. Ed. Nasonov E. Moscow: IMA-Press; 2013. (In Russ.)"},{"key":"key-10.17116\/terarkh20168854-12-24","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.91"},{"key":"key-10.17116\/terarkh20168854-12-25","doi-asserted-by":"crossref","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011;70:482-487.","DOI":"10.1136\/ard.2010.135871"},{"key":"key-10.17116\/terarkh20168854-12-26","doi-asserted-by":"publisher","DOI":"10.1002\/art.39098"},{"key":"key-10.17116\/terarkh20168854-12-27","doi-asserted-by":"publisher","DOI":"10.1002\/art.39096"},{"key":"key-10.17116\/terarkh20168854-12-28","unstructured":"Nasonov E. Methotrexate: perspectives in rheumatology. M.: Filomatis; 2005. (In Russ.)"},{"key":"key-10.17116\/terarkh20168854-12-29","unstructured":"Genetically engineered biological agents in the treatment of rheumatoid arthritis. Ed. Nasonov E.. Moscow: IMA-Press; 2013. (In Russ.)"},{"key":"key-10.17116\/terarkh20168854-12-30","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009639"},{"key":"key-10.17116\/terarkh20168854-12-31","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.04.783"},{"key":"key-10.17116\/terarkh20168854-12-32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu203"},{"key":"key-10.17116\/terarkh20168854-12-33","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015\/5"},{"key":"key-10.17116\/terarkh20168854-12-34","doi-asserted-by":"crossref","unstructured":"Popkova TV, Novikova DS, Gasparyan AY, Nasonov EL. Cardiovascular effects of methotrexate in rheumatoid arthritis. Curr Med Chem. 2015;22:1903-1910.","DOI":"10.2174\/0929867322666150415122039"},{"key":"key-10.17116\/terarkh20168854-12-35","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.06.054"},{"key":"key-10.17116\/terarkh20168854-12-36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624"},{"key":"key-10.17116\/terarkh20168854-12-37","doi-asserted-by":"publisher","DOI":"10.1002\/art.37723"},{"key":"key-10.17116\/terarkh20168854-12-38","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318241c385"},{"key":"key-10.17116\/terarkh20168854-12-39","doi-asserted-by":"crossref","unstructured":"Nasonov E. Methotrexate in rheumatoid arthritis \u2014 2015: new facts and ideas. Nauchno-prakticheskaya revmatologiya. 2015;53:64-76. (In Russ.)","DOI":"10.14412\/1995-4484-2015-64-76"},{"key":"key-10.17116\/terarkh20168854-12-40","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200493"},{"key":"key-10.17116\/terarkh20168854-12-41","doi-asserted-by":"crossref","unstructured":"Erhayiem B, Pavitt S, Baxter P et al. Coronary artery disease evaluation in rheumatoid arthritis (CADERA): study protocol for a randiomized controlled trial. Trials. 2014;15:436.","DOI":"10.1186\/1745-6215-15-436"},{"key":"key-10.17116\/terarkh20168854-12-42","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20371"},{"key":"key-10.17116\/terarkh20168854-12-43","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201148"},{"key":"key-10.17116\/terarkh20168854-12-44","doi-asserted-by":"crossref","unstructured":"Mann DL, McMurray JJ, Packer M et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004;109:1594-1602.","DOI":"10.1161\/01.CIR.0000124490.27666.B2"},{"key":"key-10.17116\/terarkh20168854-12-45","doi-asserted-by":"crossref","unstructured":"Chung ES, Packer M, Lo KH et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003;107:3133-3140.","DOI":"10.1161\/01.CIR.0000077913.60364.D2"},{"key":"key-10.17116\/terarkh20168854-12-46","unstructured":"Udachkina E.V., Novikova D.S., Popkova T.V., Nasonov E.L. Rheumatoid arthritis and atherosclerosis: Role of interleukin-6. Klinicheskaya farmakologiya i terapiya. 2012;21(1):86-92."},{"key":"key-10.17116\/terarkh20168854-12-47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61931-4"},{"key":"key-10.17116\/terarkh20168854-12-48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61931-4"},{"key":"key-10.17116\/terarkh20168854-12-49","unstructured":"Popkova T, Novikova D, Panasyuk E, Avdeeva A, Udachkina E, Alexandrova E, Novikov A, Volkov A, Nasonov E. Tocilizumab impact on blood cholesterol transport and early manifestation of atherosclerosis in patients with rheumatoid arthritis. Terapevticheskii arkhiv. 2012;5:9-18. (In Russ.)"},{"key":"key-10.17116\/terarkh20168854-12-50","doi-asserted-by":"crossref","unstructured":"Udachkina E, Novikova D, Popkova T, Nasonov E. Dynamics of blood lipid parameters in patients with rheumatoid arthritis in the combined therapy tocilizumab and methotrexate compared to methotrexate monotherapy at 24-week follow-up. Ratsional\u2019naya farmakoterapiya v kardiologii. 2015;11(5):510-516. (In Russ.)","DOI":"10.20996\/1819-6446-2015-11-5-510-516"},{"key":"key-10.17116\/terarkh20168854-12-51","doi-asserted-by":"publisher","DOI":"10.1002\/art.38920"},{"key":"key-10.17116\/terarkh20168854-12-52","doi-asserted-by":"crossref","unstructured":"Novikova DS, Popkova TV, Nasonov EL. The effect of anti-B-cell therapy on the development of atherosclerosis in patients with rheumatoid arthritis. Cur Pharm Des. 2012;18:1512-1518.","DOI":"10.2174\/138161212799504768"},{"key":"key-10.17116\/terarkh20168854-12-53","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.303569"},{"key":"key-10.17116\/terarkh20168854-12-54","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.2.202"},{"key":"key-10.17116\/terarkh20168854-12-55","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2014-270-276"},{"key":"key-10.17116\/terarkh20168854-12-56","doi-asserted-by":"crossref","unstructured":"Nasonov E, Eliseev M. The role of interleukin-1 in the development of human disease. Nauchno-prakticheskaya revmatologiya. 2016;54 (accepted for publication). (In Russ.)","DOI":"10.14412\/1995-4484-2016-60-77"},{"key":"key-10.17116\/terarkh20168854-12-57","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2014.00232"},{"key":"key-10.17116\/terarkh20168854-12-58","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003199"},{"key":"key-10.17116\/terarkh20168854-12-59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.06.012"},{"key":"key-10.17116\/terarkh20168854-12-60","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00034-0"},{"key":"key-10.17116\/terarkh20168854-12-61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134088"},{"key":"key-10.17116\/terarkh20168854-12-62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.07.017"},{"key":"key-10.17116\/terarkh20168854-12-63","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2010-826"},{"key":"key-10.17116\/terarkh20168854-12-64","doi-asserted-by":"crossref","unstructured":"Xing B, Yin Y-F, Zhao L-D et al. Effect of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor on disease activity in patients with rheumatoid arthritis. Medicine. 2015;94:e572.","DOI":"10.1097\/MD.0000000000000572"},{"key":"key-10.17116\/terarkh20168854-12-65","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207714"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T21:25:05Z","timestamp":1593379505000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2016\/5\/downloads\/ru\/000040-36602015051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"alternative-id":["terarkh20168854-12"],"URL":"https:\/\/doi.org\/10.17116\/terarkh20168854-12","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}